{"id":15826,"name":"4BIO Capital","slug":"4bio-capital","website":"https://www.4biocapital.com/","hqGeo":"London, United Kingdom","stageFocus":["Seed","Series A"],"sectorTags":["Healthcare","SaaS"],"excludedSectors":[],"checkSizeMin":500000,"checkSizeMax":5000000,"thesisSummary":"Early-stage investor focused on advanced therapies and high unmet medical need. While more therapeutics-oriented than pure SaaS, the firm is deeply biotech-native and may engage where software enables R&D, translational, or clinical workflows.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Actithera","companyUrl":null,"stage":"Series A","sector":"Biotech / radiopharma","investmentYear":null,"description":"Develops advanced radiopharmaceutical therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ray Therapeutics","companyUrl":null,"stage":"Seed / Series A / Series B","sector":"Biotech / gene therapy / ophthalmology","investmentYear":null,"description":"Develops vision restoration therapies for severe retinal degeneration.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Araris Biotech","companyUrl":null,"stage":"Early-stage venture funding","sector":"Biotech / oncology / ADCs","investmentYear":null,"description":"Develops next-generation antibody-drug conjugates (ADCs).","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Trogenix","companyUrl":null,"stage":"Series A","sector":"Biotech / oncology / gene therapy","investmentYear":null,"description":"Develops precision viral immunotherapy for aggressive cancers.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ascend","companyUrl":null,"stage":"Growth / financing round","sector":"Biomanufacturing / life sciences tools","investmentYear":null,"description":"Gene and cell manufacturing specialist.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cloverleaf Bio","companyUrl":null,"stage":"Seed","sector":"Biotech / oncology / RNA therapeutics","investmentYear":null,"description":"Develops RNA-based cancer therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aptadir Therapeutics","companyUrl":null,"stage":"Seed","sector":"Biotech / therapeutics","investmentYear":null,"description":"Develops first-in-class demethylating medicines.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cytospire Therapeutics","companyUrl":null,"stage":"Series A","sector":"Biotech / therapeutics","investmentYear":null,"description":"Develops novel therapies; 4BIO’s announcement frames it as a financing round for the company.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Undecimal Bio","companyUrl":null,"stage":"Seed","sector":"Biotech / RNA therapeutics","investmentYear":null,"description":"Develops siRNA therapies beyond the liver.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":6,"partners":[{"id":51635,"name":"Dima Kuzmin","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51636,"name":"Andrew Kozlov","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51639,"name":"Vasily Fedorin","title":"Chief Operating Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/vasily-fedorin","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51640,"name":"Unknown","title":"Partner","seniority":null,"focusTags":["Advanced therapies","Biotech"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51637,"name":"Therese Liechtenstein","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/therese-liechtenstein","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":51638,"name":"Natalie Johnston","title":"Principal","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/natalie-johnston-4b10175a","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[],"contentUpdatedAt":null,"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11767,"name":"LiftScale Partners","slug":"liftscale-partners","logoUrl":null,"website":"https://weareliftscale.com/","stageFocus":["Pre-Seed"],"sectorTags":["AI / ML","SaaS"],"hqGeo":"San Francisco, CA"},{"id":547,"name":"Cocoa VC","slug":"cocoa-vc","logoUrl":null,"website":"https://www.cocoa.vc/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","SaaS"],"hqGeo":"San Francisco, CA"},{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":3892,"name":"Madrona Pioneer Fund","slug":"madrona-pioneer-fund","logoUrl":null,"website":"https://www.madrona.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Real Estate","SaaS","Enterprise","Security","Developer Tools"],"hqGeo":"Seattle, WA"},{"id":14307,"name":"Nextgen Media Ventures","slug":"nextgen-media-ventures","logoUrl":null,"website":"https://nextgennewmedia.com/","stageFocus":["Seed"],"sectorTags":["AI / ML","SaaS"],"hqGeo":"Los Angeles, CA"}],"featuredIn":[{"slug":"saas","displayName":"SaaS Investors","pageType":"industry"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"investormatch-mcp-server-claude-chatgpt","title":"Your Investor List Now Lives Inside Claude and ChatGPT"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-25T15:28:30.423Z"}